心肌灌注显像:经验教训与待完成的工作——更新
本文为《核心脏病学杂志》编辑对心肌灌注显像领域若干当前相关议题的反思,涵盖预后判断与范式转变、连续检测数据处理、缺血指导治疗中血流储备分数与灌注及心肌血流的比较、PET显像剂选择、微血管病与三支病变的鉴别、美国以外影像现状、辐射暴露、新相机特殊问题及混合成像等。
要点
- 编辑反思心肌灌注显像中预后判断与范式转变等议题。
- 讨论连续检测中灌注变化对结局的预测价值及缺血指导治疗的不同策略。
- 涉及PET显像剂比较、微血管病鉴别、辐射暴露及混合成像等话题。
核心结论
- 编辑希望上述心肌灌注显像相关议题能引起读者兴趣。
研究设计与样本
- 本文为期刊编辑撰写的述评,未报告系统检索范围或研究方法。
主要发现
- 编辑提出需反思预后判断与范式转变、连续检测数据处理、缺血指导治疗策略比较、PET显像剂选择、微血管病与三支病变鉴别、美国以外影像差异、辐射暴露、新相机特殊问题及混合成像等议题。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As the second term of our commitment to Journal begins, we, the editors, would like to reflect on a few topics that have relevance today. These include prognostication and paradigm shifts; Serial testing: How to handle data? Is the change in perfusion predictive of outcome and which one? Ischemia-guided therapy: fractional flow reserve vs perfusion vs myocardial blood flow; positron emission tomography (PET) imaging using Rubidium-82 vs N-13 ammonia vs F-18 Flurpiridaz; How to differentiate microvascular disease from 3-vessel disease by PET? The imaging scene outside the United States, what are the differences and similarities? Radiation exposure; Special issues with the new cameras? Is attenuation correction needed? Are there normal databases and are these specific to each camera system? And finally, hybrid imaging with single-photon emission tomography or PET combined with computed tomography angiography or coronary calcium score. We hope these topics are of interest to our readers.
引用
- Iskandrian AE, Dilsizian V, Garcia EV, et al. Myocardial perfusion imaging: Lessons learned and work to be done-update. J Nucl Cardiol. 2017. PMID: 29110288. doi:10.1007/s12350-017-1093-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。